Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance

Journal of Clinical Investigation

Volumn 108, Issue 8, 2001, Pages 1205-1213

  Guerra, C ^a   Navarro, P ^a   Valverde, A M ^a   Arribas, M ^a   Bruning J ^a   Kozak, L P ^a   Kahn, C R ^a   Benito, M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CRELOXP; GENE PRODUCT; GLUCOSE; INSULIN; INSULIN RECEPTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY METABOLISM; GENETIC RECOMBINATION; GLUCOSE HOMEOSTASIS; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; LIPOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TISSUE SPECIFICITY; WHITE ADIPOSE TISSUE;

EID: 0034783580     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13103     Document Type: Article

References (33)

1. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
2. Protein-protein interaction in the insulin signaling and the molecular mechanism of insulin resistance
3. Role of glucose and insulin resistance in development of type II diabetes mellitus: Results of 25 year follow-up study
4. Insulin action, diabetogenes, and the cause of type II diabetes
5. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes
6. Insulin resistance and non-insulin dependent diabetes mellitus: Cellular and molecular mechanisms
7. Differential regulation of insulin on insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phophatidylinositol 3-kinase isoforms in liver and muscle of obese diabetic (ob/ob) mouse
8. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidyl inositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus
9. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
10. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality
11. Alternative pathways of insulin signaling in mice with targeted disruption of the IRS-1 gene
12. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
13. Disruption of IRS-2 causes type-2 diabetes in mice
14. Irs-2 coordinates Igf-1 receptor-mediated betacell development and peripheral insulin signaling
15. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
16. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
17. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
18. Loss of insulin signaling in heparocytes leads to severe insulin resistance and progressive hepatic dysfunction
19. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type II diabetes
20. Role of brain insulin receptor in control of body weight and reproduction
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Insulin like growth factor-I and insulin induce adipogenic-related gene expression in foetal brown adipocyte primary cultures
23. IRS-1 and IRS-2 differential signaling in the insulin/IGF-I pathways in fetal brown adipocytes
24. Adipocyte differentiation: A transcriptional regulatory cascade
25. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
26. Transcriptional activation of adipogenesis
27. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity
28. Uncoupling protein-2 negatively regulates insulin secretion and is the major link between obesity, β cell dysfunction, and type-2 diabetes
29. Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells
30. 3-selective agonist-induced effects on energy expenditure, insulin secretion and food intake
31. Life without white fat: A transgenic mouse
32. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
33. Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice